Carotid Artery Disease Market Research Report - Forecast till 2030

Carotid Artery Disease Market: Information by Diagnosis & Treatment (Carotid Artery Disease and Antihypertensive Drugs), End User (Hospital & Clinics, Ambulatory Surgical Centers and Pharmacies) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2030

ID: MRFR/MED/4840-CR | July 2019 | Region: Global | 157 pages

Carotid Artery Disease Market Speak to Analyst Request a Free Sample

Carotid Artery Disease Market Overview


The carotid artery disease market is projected to grow at a substantial rate. it is projected that the market will record a CAGR of 4.52%. also, according to MRFR analysis, the market value will increase up to USD 15,341.09 million during the forecast period 2021-2030. the growing demand for carotid artery disease natural treatment is pushing the market at a substantial rate. some of the factors that are driving the market growth are the growing population of the older populations, growing awareness for treatment for carotid artery disease. hence, the market will have substantial growth.


Carotid arteries are basically the blood vessels that help in supplying oxygen-enriched blood to the brain. The vessels usually get blocked due to calcium, cholesterol, etc. Proper medication can help in clearing the blockage in the blood vessels and carotid arteries. The carotid artery disease market on the basis of region is divided into South America, North America, Europe, Asia-Pacific, and the Middle East and Africa. According to the MRFR analysis, North America will hold the dominant share in the carotid artery disease alternative treatment. However, the Asia-Pacific region will grow at a substantial CAGR during the forecast period as well.


Furthermore, there are some restraints that can affect the market growth during the forecast period as well. The increasing costs of treatments and diagnosis for chronic diseases can slow down growth. Along with that, the slow diagnosis process and strict regulations can hamper the market growth. However, with the presence of several key players and the investments, the Carotid artery disease market will hold its position in the upcoming years.


Covid-19 Analysis Of Carotid Artery Disease Market


The prevalence of Coronavirus disease across the world had put a huge strain upon the Carotid artery disease market.  The growing number of affected patients with COVID-19 has affected the treatment of patients with other diseases. Also, it has put severe pressure on the economic condition of countries across the world. Due to border lockdowns in several countries, several factories were closed and it halted the production of various components used in the carotid artery disease and stenosis treatment. However, after the waiver on lockdowns, the market is reviving slowly and gradually. Thus, the market is projected to regain its growth in the upcoming years.


Carotid Artery Disease Treatment Market Share, by Medication, 2017 (%)  Carotid Artery Disease Market


Source: MRFR Analysis


Carotid artery disease market Dynamics


Market Drivers


The major drivers for the carotid artery disease and stenosis treatment are the growing population of the older generation and the huge prevalence of unhealthy lifestyles. Apart from that, the increasing use of OTD or “over-the-counter drugs” will also fuel the carotid artery disease market growth in the upcoming period.


Restraints


There are some restraints that can reduce the market growth in the upcoming years. One of the major restraints for the market is the strict regulations by the government for the treatment for carotid artery disease. Along with that, low availability of resources on the ground level can hamper market growth.


Opportunities


Some opportunities are projected to boost the market growth to a new level. Due to the growing awareness among patients for new technologies that help in early detection will open new opportunities for the market. Along with that, the improvement in treatments for stroke and heart attack will further boost the carotid artery disease market growth.


Challenges


Despite various growth opportunities, the carotid artery disease market will have some challenges. the increased cost for the carotid artery disease natural treatment will be a major challenge for people to diagnose and provide the treatment. thus, it can be a major factor affecting the market.


Cumulative Analysis


The carotid artery disease market is estimated to have robust growth. the compound annual growth rate (CAGR) of the market is expected to grow at 4.1%. the market value is estimated to increase further up to usd 15,000 million in the forthcoming years. various factors are expected to fuel the carotid artery disease alternative treatment.


Value Chain Analysis


The carotid artery disease market will have a lucrative growth with various market developments. The growing investments by key players and the increasing prevalence of diseases related to cholesterol and heart will promote the carotid artery disease market extensively.


Asia-Pacific Carotid Artery Disease IndustryShare, by Region, 2017 (%)


 Carotid Artery Disease Market


Source: MRFR Analysis


Market Segmentations


The segmentation of the carotid artery disease market is divided into end-user and type. on the basis of type, the carotid artery disease market is divided into surgery, medication, and diagnosis. the diagnosis segment is divided into Duplex Ultrasound, Compound Tomography, Magnetic Resonance Imaging, and others. On the basis of treatment, the carotid artery disease market is again divided into antihypertensive drugs, antiplatelet drugs, and cholesterol-lowering statins. On the basis of surgery, the market is again divided into carotid artery angioplasty, carotid artery bypass, and carotid endarterectomy. On the basis of end-user, the carotid artery disease market is divided into clinics and hospitals, pharmacies, ambulatory surgical centers.


Regional Analysis


The carotid artery disease market is divided into south america, north america, asia-pacific, europe, and the middle east and africa. north america is estimated to hold the largest share in the market in the forthcoming years. the growing rate of the older generation and cases of life-threatening diseases in countries such as the united states and canada will cause robust growth in the forthcoming years.


Apart from that, Europe and Asia-Pacific will also have a robust growth as compared to past years. The growing spends by the government of countries in these regions in the healthcare sector is the major driver for carotid artery disease and stenosis treatment. Also, the significant development in the infrastructure, treatment and new drugs will play a major role in the growth in these regions.


Competitive Landscape


Some of the major key players fuelling the growth of the Carotid artery disease market are as follows.



  • Medtronic Plc

  • Pfizer

  • GE Healthcare

  • Cardinal Health

  • Eli Lily and Company

  • AdvanceCor GmbH

  • Teleflex, Siemens Healthcare

  • Daiichi Sankyo Co. Ltd.

  • Abbot Laboratories

  • Bristol-Myers Squibb

  • Merck & Cp. Inc.

  • Silk Road Medical

  • Stryker Corporation

  • Hitachi

  • Terumo Corporation

  • Boston Scientific Corporation

  • Dickinson Company

  • L. Gore & Associates, Inc.


Recent Developments



  • Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.

  • Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.


Report Overview


The overview of the carotid artery disease and stenosis treatment market is as follows.



  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development


Report Score and Segmentation



  • Study Period- 2021-2028

  • Base Year-2021

  • Forecast Period- 2021-2028

  • Historical Period-2019-2020


The report score of the treatment for carotid artery disease market highlights the growth of the market in the forecast period 2021-2028. It highlights various factors such as opportunities, drivers, market value, etc., and notable key players that will push the market.


Segmentation


By Type



  • Treatment

  • Diagnosis

  • Duplex Ultrasound

  • Compound Tomography

  • Magnetic Resonance Imaging

  • Others


By Medications



  • Antiplatelet Drugs

  • Cholesterol-Lowering Statins

  • Antihypertensive Drugs


By Surgical Procedures



  • Carotid Artery Angioplasty

  • Carotid Artery Bypass

  • Carotid Endarterectomy


 By End-User



  • Clinics and Hospitals

  • Pharmacies

  • Ambulatory Surgical Centres                                  


By Region



  • North America

  • Latin America

  • Asia-Pacific

  • Europe

  • The Middle east Africa



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2030: USD 15,341.09 Million
  • 2027: Significant Value
  •   CAGR   4.52% (2020-2030)
      Base Year   2019
      Forecast Period   2020-2030
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Diagnosis & treatment, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   W. L. Gore & Associates, Inc., Becton, Dickinson and Company, Terumo Corporation, Hitachi, Ltd, Silk Road Medical, Inc., Abbott, Medtronic, Stryker Corporation, Cardinal Health, and Boston Scientific Corporation.
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Increasing geriatric population
  • Increasing adoption of an unhealthy lifestyle
  • The popularity of over-the-counter (OTD) drugs


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Carotid artery disease market projected to grow at approximately 4.52% CAGR during the assessment period (2020-2030).

    The valuation of the carotid artery disease market is estimated to increase to USD 15,341.09 MN by the end of 2030.

    Rising prevalence and demand for early diagnosis & treatment of the condition are major tailwinds pushing the growth of the global carotid artery disease market.

    North America holds the largest share in the global carotid artery disease market, followed by Europe and the Asia Pacific, respectively.

    Becton, Dickinson and Company, Hitachi Ltd., W. L. Gore & Associates, Inc., Terumo Corporation, Abbott, Medtronic, Silk Road Medical, Inc., Stryker Corporation, Boston Scientific Corporation, and Cardinal Health, are some of the top players operating in the global carotid artery disease market.